US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist
  • 77.180
  • +1.740+2.31%
Close Dec 23 16:00 ET
  • 77.180
  • 0.0000.00%
Post 16:00 ET
3.88BMarket Cap32.02P/E (TTM)

Haemonetics Key Stats

Haemonetics Q2 2025 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
342.58M
345.51M
+2.93M
Beat Est.
+7.67%
+8.59%
+0.86%
EPS
0.77
0.66
-0.11
Miss Est.
+60.00%
+37.50%
-14.06%
Strong Buy

Dec 20, 2024

Haemonetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 359.055M--
--2025/Q3-- / 352.937M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--
May 9, 20242024/Q4343.290M / 329.468M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 359.055M--
--2025/Q3-- / 352.937M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--
May 9, 20242024/Q4343.290M / 329.468M--

Unlock Free Earnings Estimates

Haemonetics Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 20, 2024

Strong Buy

  • Buy

    87.50%
  • Hold

    12.50%
  • Sell

    0.00%

Price Target

No Data